254 related articles for article (PubMed ID: 36966276)
1. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma.
Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S
BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276
[TBL] [Abstract][Full Text] [Related]
2. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
[TBL] [Abstract][Full Text] [Related]
3. IRF4 as a novel target involved in malignant transformation of oral submucous fibrosis into oral squamous cell carcinoma.
Meng L; Jiang Y; You J; Zhao P; Liu W; Zhao N; Yu Z; Ma J
Sci Rep; 2023 Feb; 13(1):2775. PubMed ID: 36797470
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.
Zheng L; Guan ZJ; Pan WT; Du TF; Zhai YJ; Guo J
Oncol Res; 2018 Apr; 26(3):483-494. PubMed ID: 28550687
[TBL] [Abstract][Full Text] [Related]
5. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
[TBL] [Abstract][Full Text] [Related]
6. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
[TBL] [Abstract][Full Text] [Related]
7. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
[TBL] [Abstract][Full Text] [Related]
8. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
[TBL] [Abstract][Full Text] [Related]
9. Study on the expression and function of smad family member 7 in oral submucous fibrosis and oral squamous cell carcinoma.
Hu X; Xiong H; Wang W; Huang L; Mao T; Yang L; Wang C; Huang D; Wu J; Xia K; Su T
Arch Oral Biol; 2020 Apr; 112():104687. PubMed ID: 32114253
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of oral squamous cell carcinoma with oral submucous fibrosis.
Saalim M; Sansare K; Karjodkar FR; Johaley S; Ali IK; Sharma SR; Mehra A; Rahman B
J Cancer Res Ther; 2021; 17(6):1510-1514. PubMed ID: 34916386
[TBL] [Abstract][Full Text] [Related]
11. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
Yu CC; Tsai CH; Hsu HI; Chang YC
PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
[TBL] [Abstract][Full Text] [Related]
12. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
Shieh DH; Chiang LC; Shieh TY
Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
[TBL] [Abstract][Full Text] [Related]
13. Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis.
Chen J; Li W; Liu B; Xie X
BMC Oral Health; 2022 Jul; 22(1):316. PubMed ID: 35906577
[TBL] [Abstract][Full Text] [Related]
14. Identification of a BRAF/PA28γ/MEK1 signaling axis and its role in epithelial-mesenchymal transition in oral submucous fibrosis.
Xie C; Li Z; Hua Y; Sun S; Zhong L; Chen Q; Feng H; Ji N; Li T; Zhou X; Zeng X; Tang Z; Sun C; Li J; Chen Q
Cell Death Dis; 2022 Aug; 13(8):701. PubMed ID: 35961969
[TBL] [Abstract][Full Text] [Related]
15. Skewed Th17/Treg balance during progression and malignant transformation of oral submucous fibrosis.
Liu S; Liu Z; Shan Z; Liu Y; Chen T; Fang L; Quan H
Oral Dis; 2022 Nov; 28(8):2119-2130. PubMed ID: 33749974
[TBL] [Abstract][Full Text] [Related]
16. An Evaluation of Clinical and Histopathological Aspects of Patients with Oral Submucous Fibrosis in the Background of Oral Squamous Cell Carcinoma.
Siriwardena BSMS; Jayawardena KLTD; Senarath NH; Tilakaratne WM
Biomed Res Int; 2018; 2018():4154165. PubMed ID: 30402477
[TBL] [Abstract][Full Text] [Related]
17. Effects of arecoline, safrole, and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan.
Shieh DH; Chiang LC; Lee CH; Yang YH; Shieh TY
J Oral Pathol Med; 2004 Oct; 33(9):581-7. PubMed ID: 15357680
[TBL] [Abstract][Full Text] [Related]
18. Fat mass and obesity-associated protein regulates tumorigenesis of arecoline-promoted human oral carcinoma.
Li X; Xie X; Gu Y; Zhang J; Song J; Cheng X; Gao Y; Ai Y
Cancer Med; 2021 Sep; 10(18):6402-6415. PubMed ID: 34378866
[TBL] [Abstract][Full Text] [Related]
19. The effects of arecoline on the release of cytokines using cultured peripheral blood mononuclear cells from patients with oral mucous diseases.
Hsu HJ; Chang KL; Yang YH; Shieh TY
Kaohsiung J Med Sci; 2001 Apr; 17(4):175-82. PubMed ID: 11482128
[TBL] [Abstract][Full Text] [Related]
20. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
